DLX-2270

N/A

Report date: 2025/09/29 16:01:37
NME

Base Information

Drug NameDLX-2270
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2a (5-HT2a) receptor antagonistsSerotonin 2c (5-HT2c) receptor agonists
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDelix Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesDelix Therapeutics
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A